In adults with active dermatomyositis, IV immune globulin improved treatment response at 16 wk vs. placebo. Schattner A. Ann Intern Med 2023;176:JC22.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schattner A. In adults with active dermatomyositis, IV immune globulin improved treatment response at 16 wk vs. placebo. Ann Intern Med 2023;176:JC22.
PMID: 36745896